Vasectomy Comments

Executive Summary

These comments were submitted in response to Notice 2018-12, in which the Internal Revenue Service (“IRS”) requested comments on the appropriate standards for preventive care under § 223(c)(2)(C) of the Internal Revenue Code of 1986 and “other issues related to the provision of preventive care” under a high deductible health plan. Our comments strongly recommend that the IRS and the Treasury Department issue guidance clarifying the definition of “preventive care” under § 223(c)(2)(C) to include all contraceptive drugs, devices, and sterilization procedures recognized by the U.S. Food & Drug Administration, as well as patient education and counseling, because all of these methods are designed and used to prevent unintended pregnancies.

Related Content

Giving Tuesday

 
 

Thank you for joining NHeLP in celebration of GivingTuesday. Your support empowers us in the fight to protect and advance health rights. Make a donation to NHeLP in honor of the global day of generosity now!